Year: 2024

Estee Lauder forecasts lower profits and Freda announces her retirement

Estee Lauder forecasts lower profits and Freda announces her retirement

Estee Lauder Chairman and CEO Fabrizio Freda will retire, marking the end of an impactful era for the cosmetics giant. Estee Lauder forecast its annual sales and profits will fall short of expectations as the global beauty industry faces declining demand, particularly in China. The announcement comes amid news that CEO Fabrizio Freda, who has led the company since 2009, will step down on June 30, 2025, ending nearly 16 years of leadership. During her tenure, Freda, 66, has significantly expanded Estee Lauder’s skin care line, incorporating popular brands like Dr. Jart and Deciem, which owns The Ordinary. She has…
Read More
Social networking giant X halts operations in Brazil amid legal and censorship challenges

Social networking giant X halts operations in Brazil amid legal and censorship challenges

MEXICO CITY — Social media giant X said Saturday it would cease operations in Brazil, a move that comes after Brazilian Supreme Court Justice Alexandre de Moraes reportedly ordered the arrest of X’s legal representative in Brazil unless specific warrants were complied with. X announced an immediate withdrawal of its staff from its Brazilian operations, although it mentioned that Brazilian users would still have access to its services. The company did not clarify the apparent contradiction in continuing to offer services while suspending operations. This announcement follows a series of meetings earlier this year between X representatives and Judge de…
Read More
Goldman Sachs reduces probability of U.S. recession to 20% after positive economic indicators

Goldman Sachs reduces probability of U.S. recession to 20% after positive economic indicators

Goldman Sachs has lowered its forecast for a potential US recession to 20%, following a reassessment prompted by the latest employment and retail trade data. The change comes after it raised its recession probability earlier this month, initially pegged at 25% due to disappointing job growth figures in early August. Earlier, Goldman Sachs economic analysts had raised their recession risk estimates when the July jobs report showed nonfarm payrolls rose by just 114,000, significantly below expectations and down from the revised June figures. The disappointing report contributed to a temporary stock market downturn and raised alarms about the potential weakening…
Read More
Gabapentin: versatile pain management solution gaining popularity among the elderly

Gabapentin: versatile pain management solution gaining popularity among the elderly

Gabapentin, a drug originally developed for epilepsy, has found new life as a multipurpose pain reliever adopted by seniors for ailments ranging from nerve pain to muscle aches. This versatile medication has become a daily staple for many seniors seeking relief from chronic conditions. In Manchester-by-the-Sea, Massachusetts, Mary Peart, 67, a retired nurse, recounts her experience with gabapentin, which she began using a year and a half ago to ease symptoms of fibromyalgia. The drug has significantly improved her mobility, allowing her to do daily activities like climbing stairs, walking her dog, and taking art classes. “It’s transformative,” she notes.…
Read More